Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

✍ Scribed by Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morlion; Jerry Snidow; Amy Pierce; Eric Mortensen; Christi Kleoudis; Eric Carter

• Book ID: 116818490
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 723 KB
• Volume: 137
• Category: Article
• ISSN: 0304-3959
• DOI: 10.1016/j.pain.2007.11.008